CA
CLX icon

Cullinan Associates’s Clorox CLX Stock Holding History

Cullinan Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,175
Closed -$453K – 246
2023
Q4 		$453K Sell
3,175
-2,300
-42% -$307K 0.03% 188
2023
Q3 		$718K Sell
5,475
-1,300
-19% -$198K 0.04% 162
2023
Q2 		$1.08M Buy
+6,775
New +$1.09M 0.06% 152
2023
Q1 		– Sell
-2,019
Closed -$283K – 250
2022
Q4 		$283K Buy
+2,019
New +$287K 0.02% 247
2015
Q3 		– Sell
-4,820
Closed -$501K – 213
2015
Q2 		$501K Buy
4,820
+100
+2% +$10.8K 0.04% 175
2015
Q1 		$521K Buy
+4,720
New +$512K 0.04% 175
2014
Q4 		– Sell
-19,945
Closed -$1.92M – 89
2014
Q3 		$1.92M Buy
19,945
+4,690
+31% +$424K 0.22% 60
2014
Q2 		$1.27M Buy
+15,255
New +$1.37M 0.21% 63
2014
Q1 		– Sell
-12,790
Closed -$1.19M – 89
2013
Q4 		$1.19M Buy
12,790
+1,060
+9% +$95.5K 0.14% 67
2013
Q3 		$958K Sell
11,730
-8,845
-43% -$747K 0.13% 72
2013
Q2 		$1.71M Buy
+20,575
New +$1.77M 0.23% 57

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Cullinan Associates's CLX Position: Q1 2024 in Review

Cullinan Associates sold out of Clorox (CLX) in Q1 2024, closing a stake of 3,175 shares — an estimated $453K sold.

Cullinan Associates first reported a position in CLX in Q2 2013 and held it in 11 quarters. The position peaked at $1.92M in Q3 2014. 1,143 funds tracked by Wall St. Rank hold CLX as of Q1 2024.

  • Cullinan Associates reported no remaining Clorox position as of Q1 2024 after selling out during the quarter.
  • Cullinan Associates sold 3,175 Clorox shares in Q1 2024, an estimated $453K.
  • Cullinan Associates first reported a position in Clorox in Q2 2013 and held it in 11 quarters.
  • Cullinan Associates's Clorox position peaked at $1.92M in Q3 2014.
  • 1,143 funds tracked by Wall St. Rank held Clorox as of Q1 2024.

Based on Cullinan Associates's 13F filing for Q1 2024, filed 18 Apr 2024.